| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.03 | 0.8 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |